Biofortified chicken and eggs prevented winter vitamin D decline, yet a 1,000 IU supplement was needed to raise levels
An 8-week randomized trial in The American Journal of Clinical Nutrition found that eating 25(OH)D3-biofortified chicken and eggs held blood vitamin D steady over the winter, whereas only a daily 1,000 IU supplement actively increased serum levels.
Eating poultry and eggs biofortified with 25-hydroxyvitamin D3 preserves circulating vitamin D through the winter months, according to a randomized controlled trial published in The American Journal of Clinical Nutrition. The intervention kept blood levels steady during seasonal sun deprivation, whereas a standard daily 1,000 IU vitamin D3 supplement actively elevated serum concentrations. For adults planning their cold-weather regimen, these findings clarify the boundary between food-based maintenance and supplement-driven repletion. 1
How the winter trial was structured
Researchers at Cornell University evaluated whether incorporating biofortified animal foods into a normal diet could prevent the drop in blood vitamin D that occurs during high-latitude winters. The trial enrolled 57 healthy adults with an average age of 22.6 years and a mean BMI of 24.0 kg/m² in Ithaca, New York, where cutaneous vitamin D synthesis drops to negligible levels between January and March. 2
The investigators randomly assigned participants to one of three parallel 8-week interventions:
- The 25D3 Biofortified Food group (19 participants) consumed 1,500 grams weekly of chicken meat enriched with 25-hydroxyvitamin D3 during weeks 1 through 8, added five biofortified eggs per week during weeks 5 through 8, and took daily placebo capsules.
- The D3 Supplement group (19 participants) consumed standard control chicken and eggs while taking a daily oral capsule containing 1,000 IU (25 micrograms) of vitamin D3.
- The Placebo group (19 participants) consumed standard control chicken and eggs while taking daily placebo capsules.
All participants provided fasting blood samples every two weeks. The laboratory team analyzed serum 25-hydroxyvitamin D [25(OH)D] and related metabolites using liquid chromatography–tandem mass spectrometry (LC-MS/MS), tracking circulating concentrations over time with linear mixed-effects models. 1
What the blood measurements revealed
The 8-week winter protocol created clear divergence among the three groups. Participants receiving placebo capsules alongside standard grocery-style chicken and eggs experienced a steady downward drift in circulating vitamin D. In contrast, those consuming biofortified poultry products stabilized their starting levels, and those taking the daily 1,000 IU supplement achieved higher circulating status. 1
| Intervention arm | Weekly vitamin D delivery | 8-week change in serum 25(OH)D | Week 8 insufficiency rate (< 20 ng/mL) | Clinical takeaway |
|---|---|---|---|---|
| Placebo group (n=19) | Standard chicken + 5 standard eggs (~207 IU/wk total egg D3) + placebo capsule | Decreased by 4.4 ng/mL (95% CI: −7.7 to −1.7; P < 0.05) | 47% of participants | Standard poultry and eggs allow substantial seasonal decline in circulating status |
| 25D3 Biofortified group (n=19) | 1,500 g biofortified chicken + 5 biofortified eggs (~560 IU/wk egg D3 equivalent) + placebo capsule | Maintained baseline concentrations (0.0 ng/mL net change; final mean: 25.5 ng/mL) | 11% of participants | Specialized biofortified foods prevent winter decline and support maintenance |
| D3 Supplement group (n=19) | Standard chicken + 5 standard eggs (~210 IU/wk total egg D3) + daily 1,000 IU D3 pill (~7,000 IU/wk) | Increased by 4.3 ng/mL (95% CI: 1.0 to 7.5; P < 0.05; final mean: 32.5 ng/mL) | 0% of participants | Daily oral supplementation reliably raises circulating levels and eliminates insufficiency |
The numerical spread between groups illustrates the functional difference between whole-food biofortification and oral capsules. Placebo participants finished the 8 weeks with an average serum concentration of 19.7 ng/mL, leaving almost half the group below the standard 20 ng/mL sufficiency threshold. Eating 25(OH)D3-enriched chicken and eggs preserved baseline levels around 25.5 ng/mL, reducing late-winter insufficiency to 11%. Meanwhile, the 1,000 IU daily capsule drove average serum levels to 32.5 ng/mL, keeping every participant in the optimal range. 3
Production realities and clinical boundaries
Interpreting this study requires distinguishing experimental agricultural techniques from current supermarket realities. The biofortified poultry in this trial was produced by supplementing hen feed directly with 25-hydroxyvitamin D3, a metabolite that incorporates into muscle tissue and egg yolks more efficiently than standard cholecalciferol. Conventional commercial poultry feeds rely on standard vitamin D3 at baseline regulatory levels. As the trial's control data show, ordinary supermarket chicken and eggs supply only around 200 IU across five whole eggs, an amount insufficient to halt winter depletion. 1
The study population also defines the boundaries of application. The trial examined healthy young adults with normal body mass index and intact digestive absorption. Populations with higher metabolic requirements—including older adults with reduced renal 1-alpha-hydroxylase activity, individuals with obesity whose adipose tissue sequesters fat-soluble vitamins, and patients with celiac disease or inflammatory bowel disorders—exhibit different absorption dynamics. For these groups, reliance on dietary intake alone carries a higher probability of persistent insufficiency.
The trial was formally registered under identifier NCT05248737 and conducted with institutional oversight at Cornell University's Human Metabolic Research Unit. The authors reported no commercial conflicts of interest. The manuscript was published online by The American Journal of Clinical Nutrition on September 9, 2026. 1
The same-day dietary decision
Health-conscious individuals and registered dietitians can translate these experimental findings into direct practice:
- Maintain daily vitamin D3 supplementation during winter months. If your goal is to elevate low blood concentrations or guarantee status above 30 ng/mL between October and April, rely on a verified oral supplement supplying 1,000 to 2,000 IU (25 to 50 micrograms) daily.
- Treat conventional chicken and eggs as valuable protein, rather than primary vitamin D sources. Whole eggs and poultry provide choline, lutein, and high-quality protein, but standard grocery varieties supply only modest amounts of vitamin D (roughly 40 to 45 IU per egg).
- Recognize the distinct role of emerging biofortified foods. If 25(OH)D3-enriched animal products reach retail markets, view them as an effective dietary shield against seasonal decline, while reserving oral supplements for active therapeutic repletion.
- Base dose adjustments on objective serum 25(OH)D blood tests. Request a total serum 25(OH)D test during annual health screenings to establish your winter baseline and verify that your selected daily intake meets your target range.
References
- 1PubMed record and abstract for the biofortified poultry and egg trial
pubmed.ncbi.nlm.nih.gov
- 2ClinicalTrials.gov registry details for NCT05248737
clinicaltrials.gov
- 3Nutritional trial reporting on secondary metabolite trajectories
cdn.nutrition.org
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.